J. Faillie

First name
Middle name
Last name
Faillie, J. L., Azoulay, L., Patenaude, V., Hillaire-Buys, D., & Suissa, S. (2014). Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study. Bmj. http://doi.org/10.1136/bmj.g2780
Faillie, J. L., Filion, K. B., Patenaude, V., Ernst, P., & Azoulay, L. (2015). Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes. Diabetes Obes Metab. http://doi.org/10.1111/dom.12431
Faillie, J. L., Yu, O. H., Yin, H., Hillaire-Buys, D., Barkun, A., & Azoulay, L. (2016). Association of Bile Duct and Gallbladder Diseases With the Use of Incretin-Based Drugs in Patients With Type 2 Diabetes Mellitus. JAMA Intern Med. http://doi.org/10.1001/jamainternmed.2016.1531
Abrahami, D., Douros, A., Yin, H., Yu, O. H., Faillie, J. L., Montastruc, F., et al. (2018). Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study. Bmj. http://doi.org/10.1136/bmj.k4880
Faillie, J. L., Yin, H., H. Y. Yu, O., Herrero, A., Altwegg, R., Renoux, C., & Azoulay, L. (2021). Incretin-Based Drugs and Risk of Intestinal Obstruction Among Patients with Type 2 Diabetes. Clin Pharmacol Ther. http://doi.org/10.1002/cpt.2430